Cargando…
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
BACKGROUND: There is significant variation in Amphotericin B (AMB) efficacy and relapses in antimony unresponsive visceral leishmaniasis (VL) cases over a period of time (10–15 years). Keeping in mind the above mentioned view this study was undertaken with an objective to assess the magnitude of cur...
Autores principales: | Das, Vidya Nand Rabi, Siddiqui, Niyamat Ali, Pandey, Krishna, Singh, Vijay Pratap, Topno, Roshan K, Singh, Dharmendra, Verma, Rakesh Bihari, Ranjan, Alok, Sinha, Prabhat Kumar, Das, Pradeep |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697519/ https://www.ncbi.nlm.nih.gov/pubmed/19436614 |
Ejemplares similares
-
Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India
por: Das, Vidya Nand Rabi, et al.
Publicado: (2021) -
Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016) -
Comparative Analysis of the Omics Technologies Used to Study Antimonial, Amphotericin B, and Pentamidine Resistance in Leishmania
por: Kaur, Gagandeep, et al.
Publicado: (2014) -
To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)
por: Rabi Das, Vidya Nand, et al.
Publicado: (2017) -
Kala-azar elimination in a highly-endemic district of Bihar, India: A success story
por: Kumar, Vijay, et al.
Publicado: (2020)